First Trust Health Care AlphaDEX Fund Rating $117.52 0.00 (0.00%) Closing price 06/12/2026 04:10 PM EasternExtended Trading$117.74 +0.23 (+0.19%) As of 06/12/2026 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsSEC FilingsShort InterestBuy This Stock First Trust Health Care AlphaDEX Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FXH Aggregate RatingHold 2.40Holdings in FXH have an aggregate rating of Hold based on 451 analyst ratings issued in the past year covering 25 companies (54.9% of the portfolio).FXH Aggregate Price Target$117.52High Prediction$117.52Average Prediction$117.52Low Prediction$117.52Holdings in FXH have an aggregate price target of $117.52 and a range of $117.52 to $117.52 covering 25 companies (54.9% of the portfolio).FXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold13 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Health Care AlphaDEX Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FXH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.33%HUMHumana$379.42+0.1%2.1659 of 5 stars2.21$291.35 -23.2%28Gap Down3.77%OGNOrganon & Co.$13.46+0.1%2.932 of 5 stars1.71$11.40 -15.3%7Positive News3.01%ELVElevance Health$403.74-0.1%4.3426 of 5 stars2.61$416.11 3.1%23Positive News2.63%DVADaVita$208.31-0.2%4.0861 of 5 stars2.38$199.17 -4.4%82.54%EXELExelixis$53.133.0561 of 5 stars2.39$47.35 -10.9%23Positive News2.54%SOLVSolventum$78.850.0%2.6574 of 5 stars2.50$84.25 6.8%142.51%MOHMolina Healthcare$200.55+0.1%3.1866 of 5 stars2.06$182.73 -8.9%16Positive NewsGap Down2.29%CICigna Group$297.77-0.1%4.8891 of 5 stars2.77$338.80 13.8%22Positive News2.25%INCYIncyte$108.532.8442 of 5 stars2.32$105.10 -3.2%222.21%BIIBBiogen$200.053.5817 of 5 stars2.55$217.26 8.6%292.20%BIOBio-Rad Laboratories$285.50-0.2%1.0672 of 5 stars2.00$303.33 6.2%52.04%CAHCardinal Health$223.760.0%4.0914 of 5 stars2.94$246.93 10.4%17Analyst Downgrade2.03%ZBHZimmer Biomet$88.540.0%4.696 of 5 stars2.26$102.70 16.0%23Positive News1.96%CHEChemed$419.07-0.1%4.6225 of 5 stars2.33$501.50 19.7%61.91%GMEDGlobus Medical$80.44+0.1%4.5896 of 5 stars2.87$106.36 32.2%151.76%EHCEncompass Health$101.49+0.0%4.7934 of 5 stars3.00$143.86 41.7%9Positive News1.71%MASIMasimo$179.951.7248 of 5 stars2.00$180.40 0.3%91.68%UHSUniversal Health Services$146.400.0%4.8002 of 5 stars2.28$218.63 49.3%181.67%REGNRegeneron Pharmaceuticals$612.144.8577 of 5 stars2.70$792.65 29.5%27Positive News1.67%MRKMerck & Co., Inc.$119.05+0.0%4.468 of 5 stars2.68$128.18 7.7%19Trending NewsOptions VolumeGap Up1.66%AMGNAmgen$355.203.8153 of 5 stars2.48$354.12 -0.3%31Trending NewsAnalyst Forecast1.65%IONSIonis Pharmaceuticals$73.283.6192 of 5 stars2.90$100.90 37.7%21Positive News1.64%PENPenumbra$318.630.0%2.3086 of 5 stars2.18$361.33 13.4%171.62%ILMNIllumina$160.972.2516 of 5 stars2.33$142.13 -11.7%18Positive NewsGap Up1.61%HCAHCA Healthcare$387.25+0.0%4.7728 of 5 stars2.58$506.14 30.7%24 This page (NYSEARCA:FXH) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Health Care AlphaDEX Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Health Care AlphaDEX Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
